Loading...

Home
ETF
ERAS

ERAS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ERAS News

Erasca Under Investigation for Securities Law Violations

5d agoGlobenewswire

Block & Leviton Investigates Erasca for Potential Securities Violations

5d agoNewsfilter

Erasca Stock Surges 16.9% Amid Optimism for Cancer Treatment

May 01 2026Yahoo Finance

Erasca Shares Plunge 48% Following Patient Death

Apr 28 2026Fool

Tech Stocks Decline Following OpenAI Misses

Apr 28 2026CNBC

Erasca Faces Investor Claims Investigation

Apr 28 2026Globenewswire

Erasca Under Investigation for Potential Securities Violations

Apr 28 2026Newsfilter

Erasca's Cancer Drug Trial Data Triggers Stock Plunge

Apr 28 2026seekingalpha

Erasca Releases Positive Preliminary Data for ERAS-0015

Apr 28 2026NASDAQ.COM

Erasca's Cancer Therapy Trial Reports Treatment-Related Death

Apr 28 2026stocktwits

Erasca Discusses Preliminary Phase 1 Data for ERAS-0015

Apr 27 2026NASDAQ.COM

Erasca Announces Preliminary Phase 1 Data for ERAS-0015

Apr 27 2026Newsfilter

Revolution Medicines Requests Erasca Inc. to Halt U.S. Operations for ERAS-0015 and Related Statements - SEC Filing

Apr 27 2026moomoo

Erasca Inc. Faces Allegations of Trade Secret Misappropriation from Revolution Medicines Concerning ERAS-0015 - SEC Filing

Apr 27 2026moomoo

Revolution's Cancer Drug Shows Promising Results in Trials

Apr 13 2026stocktwits

Erasca Inc Shares Surpass Analyst Target Price

Apr 03 2026NASDAQ.COM